Abstract

The objective of this study was to develop EULAR/ACR classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients with new...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
76-Year-Old Man With New Bilateral Shoulder Pain
Miguel Teixeira ... Laura S Greenlund
Mayo Clinic Proceedings | VOL. 93
Miguel Teixeira, et. al.Miguel Teixeira ... Laura S Greenlund
01 Jul 2018
2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative
Clement J Michet ... Cynthia S Crowson
Arthritis & Rheumatism | VOL. 64
Clement J Michet, et. al.Clement J Michet ... Cynthia S Crowson
02 Mar 2012
AB1061 Interspinous Bursitis Evaluation by Ultrasound Should be Added to 2012 Provisional Classification Criteria for Polymyalgia Rheumatica
K Hatta ... K Amano
Annals of the Rheumatic Diseases | VOL. 74
K Hatta, et. al.K Hatta ... K Amano
01 Jun 2015
OP0292 Interspinous Bursitis Evaluation by Ultrasound Is Very Useful for Diagnosis of Polymyalgia Rheumatica Extension Study
K Amano ... K Kume
Annals of the Rheumatic Diseases | VOL. 75
K Amano, et. al.K Amano ... K Kume
01 Jun 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers